Tuberculosis Vaccine may be helpful in fighting Covid-19: Study
Team Udayavani, Jun 1, 2020, 11:06 AM IST
US Researchers have found that Bacillus Calmette-Guerin (BCG), a vaccine for tuberculosis (TB), could be a potential new tool in the fight against Covid-19
The study posted on medRxiv, a site for unpublished medical research, finds a correlation between countries that require citizens to get the bacillus Calmette-Guerin (BCG) vaccine and those showing fewer number of confirmed cases and deaths from Covid-19.
The study is titled ‘Correlation between universal BCG vaccination policy and reduced morbidity and mortality for Covid-19: an epidemiological study’.
Researchers compared large number of countries BCG vaccination policies with the morbidity and mortality for Covid-19.
The study found that BCG vaccination significantly reduced deaths from Covid-19, with the strongest reductions in countries that established a BCG vaccination policy earlier.
Researchers said, “We found that countries without universal policies of BCG vaccination (Italy, the Netherlands, the US) have been more severely affected compared to countries with universal and long-standing BCG policies”
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
10 month baby gets new heart, new life
World COPD Day: Know your lung function
As Delhi chokes with dangerous pollution levels, doctors warn of health risks for all
World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness
World Diabetes Day: An overview of types of diabetes
MUST WATCH
Latest Additions
Air India to offer integrated aircraft maintenance engineering programme
Awards don’t create value for independent films in India: Manoj Bajpayee
Karnataka bypolls: Outcome crucial for both ruling and oppn camps
Belagavi: Was youth killed for an iPhone? Police launch intensive probe
K’taka Health Minister calls for collaborative efforts to combat Antimicrobial Resistance
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.